NEBL-AS1

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, NEBL-AS1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NEBL-AS1 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher NEBL-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NEBL-AS1 expression acts as an unfavorable survival marker.

LGG are the cancer types where NEBL-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LGGOSMedianAll0.1340.811<.00112view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

NEBL-AS1–LGG (OS)

Kaplan–Meier survival curve for NEBL-AS1 mutant vs wild-type samples in LGG.

Open the LGG breakdown →

Exploration